| Memory Clinic, Inc. | |
|
357 Shields Dr Bennington VT 05201-9810 | |
| (802) 447-1409 | |
| Not Available |
| Full Name | Memory Clinic, Inc. |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 357 Shields Dr, Bennington, Vermont |
| Authorized Official Name and Position | Cynthia Murphy (DIRECTOR) |
| Authorized Official Contact | 8024471409 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Memory Clinic, Inc. 357 Shields Dr Bennington VT 05201-9810 Ph: () - | Memory Clinic, Inc. 357 Shields Dr Bennington VT 05201-9810 Ph: (802) 447-1409 |
| NPI Number | 1205359213 |
|---|---|
| Provider Enumeration Date | 07/21/2017 |
| Last Update Date | 03/16/2021 |
| Certification Date | 03/16/2021 |
| Medicare PECOS PAC ID | 6709209109 |
|---|---|
| Medicare Enrollment ID | O20200701002464 |
News Archive
If developing nations shift to using ecological agriculture methods, which rely more on organic and sustainable practices rather than the use of pesticides and chemical fertilizers, they "can double food production within a decade," according to a study by Olivier De Schutter, the U.N. special rapporteur on the right to food, released on Tuesday, Reuters reports.
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
Evidence reported in the October issue of Cell Metabolism, a Cell Press publication, offers a completely new explanation for why people with diabetes account for more than half of all patients requiring dialysis or kidney transplantation. It appears that insulin has a significant influence on the structure and proper function of a particular group of very specialized cells, known as podocytes, that are integral to the kidney's ability to do its job filtering blood.
Children in a malaria-endemic community in Ghana who received a micronutrient powder with iron did not have an increased incidence of malaria, according to a study in the September 4 issue of JAMA. Previous research has suggested that iron supplementation for children with iron deficiency in malaria-endemic areas may increase the risk of malaria.
BioSante Pharmaceuticals, Inc. today announced the initiation of a LibiGel (testosterone gel) clinical trial to evaluate its effect on cognitive function in menopausal women. The trial is a randomized, 6-month comparison of the effect of LibiGel compared to placebo treatment on a variety of learning and memory tasks. The study is being conducted by Dr. Susan Davis, Professor of Women's Health, Department of Medicine, Monash University Women's Health Program in Australia.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205359213 | NPI | - | NPPES |
| Provider Name | Lisa Karen Catapano Friedman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1619973690 PECOS PAC ID: 8123078490 Enrollment ID: I20050125000302 |
News Archive
If developing nations shift to using ecological agriculture methods, which rely more on organic and sustainable practices rather than the use of pesticides and chemical fertilizers, they "can double food production within a decade," according to a study by Olivier De Schutter, the U.N. special rapporteur on the right to food, released on Tuesday, Reuters reports.
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
Evidence reported in the October issue of Cell Metabolism, a Cell Press publication, offers a completely new explanation for why people with diabetes account for more than half of all patients requiring dialysis or kidney transplantation. It appears that insulin has a significant influence on the structure and proper function of a particular group of very specialized cells, known as podocytes, that are integral to the kidney's ability to do its job filtering blood.
Children in a malaria-endemic community in Ghana who received a micronutrient powder with iron did not have an increased incidence of malaria, according to a study in the September 4 issue of JAMA. Previous research has suggested that iron supplementation for children with iron deficiency in malaria-endemic areas may increase the risk of malaria.
BioSante Pharmaceuticals, Inc. today announced the initiation of a LibiGel (testosterone gel) clinical trial to evaluate its effect on cognitive function in menopausal women. The trial is a randomized, 6-month comparison of the effect of LibiGel compared to placebo treatment on a variety of learning and memory tasks. The study is being conducted by Dr. Susan Davis, Professor of Women's Health, Department of Medicine, Monash University Women's Health Program in Australia.
› Verified 4 days ago
| Provider Name | Cynthia Murphy |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1851483028 PECOS PAC ID: 9638129000 Enrollment ID: I20100824000866 |
News Archive
If developing nations shift to using ecological agriculture methods, which rely more on organic and sustainable practices rather than the use of pesticides and chemical fertilizers, they "can double food production within a decade," according to a study by Olivier De Schutter, the U.N. special rapporteur on the right to food, released on Tuesday, Reuters reports.
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
Evidence reported in the October issue of Cell Metabolism, a Cell Press publication, offers a completely new explanation for why people with diabetes account for more than half of all patients requiring dialysis or kidney transplantation. It appears that insulin has a significant influence on the structure and proper function of a particular group of very specialized cells, known as podocytes, that are integral to the kidney's ability to do its job filtering blood.
Children in a malaria-endemic community in Ghana who received a micronutrient powder with iron did not have an increased incidence of malaria, according to a study in the September 4 issue of JAMA. Previous research has suggested that iron supplementation for children with iron deficiency in malaria-endemic areas may increase the risk of malaria.
BioSante Pharmaceuticals, Inc. today announced the initiation of a LibiGel (testosterone gel) clinical trial to evaluate its effect on cognitive function in menopausal women. The trial is a randomized, 6-month comparison of the effect of LibiGel compared to placebo treatment on a variety of learning and memory tasks. The study is being conducted by Dr. Susan Davis, Professor of Women's Health, Department of Medicine, Monash University Women's Health Program in Australia.
› Verified 4 days ago
| Provider Name | Diana E Michalczuk |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1760631774 PECOS PAC ID: 5193977585 Enrollment ID: I20121211000333 |
News Archive
If developing nations shift to using ecological agriculture methods, which rely more on organic and sustainable practices rather than the use of pesticides and chemical fertilizers, they "can double food production within a decade," according to a study by Olivier De Schutter, the U.N. special rapporteur on the right to food, released on Tuesday, Reuters reports.
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
Evidence reported in the October issue of Cell Metabolism, a Cell Press publication, offers a completely new explanation for why people with diabetes account for more than half of all patients requiring dialysis or kidney transplantation. It appears that insulin has a significant influence on the structure and proper function of a particular group of very specialized cells, known as podocytes, that are integral to the kidney's ability to do its job filtering blood.
Children in a malaria-endemic community in Ghana who received a micronutrient powder with iron did not have an increased incidence of malaria, according to a study in the September 4 issue of JAMA. Previous research has suggested that iron supplementation for children with iron deficiency in malaria-endemic areas may increase the risk of malaria.
BioSante Pharmaceuticals, Inc. today announced the initiation of a LibiGel (testosterone gel) clinical trial to evaluate its effect on cognitive function in menopausal women. The trial is a randomized, 6-month comparison of the effect of LibiGel compared to placebo treatment on a variety of learning and memory tasks. The study is being conducted by Dr. Susan Davis, Professor of Women's Health, Department of Medicine, Monash University Women's Health Program in Australia.
› Verified 4 days ago
| Provider Name | Guy Bernard Debros |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1740687011 PECOS PAC ID: 7911227939 Enrollment ID: I20170106000653 |
News Archive
If developing nations shift to using ecological agriculture methods, which rely more on organic and sustainable practices rather than the use of pesticides and chemical fertilizers, they "can double food production within a decade," according to a study by Olivier De Schutter, the U.N. special rapporteur on the right to food, released on Tuesday, Reuters reports.
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
Evidence reported in the October issue of Cell Metabolism, a Cell Press publication, offers a completely new explanation for why people with diabetes account for more than half of all patients requiring dialysis or kidney transplantation. It appears that insulin has a significant influence on the structure and proper function of a particular group of very specialized cells, known as podocytes, that are integral to the kidney's ability to do its job filtering blood.
Children in a malaria-endemic community in Ghana who received a micronutrient powder with iron did not have an increased incidence of malaria, according to a study in the September 4 issue of JAMA. Previous research has suggested that iron supplementation for children with iron deficiency in malaria-endemic areas may increase the risk of malaria.
BioSante Pharmaceuticals, Inc. today announced the initiation of a LibiGel (testosterone gel) clinical trial to evaluate its effect on cognitive function in menopausal women. The trial is a randomized, 6-month comparison of the effect of LibiGel compared to placebo treatment on a variety of learning and memory tasks. The study is being conducted by Dr. Susan Davis, Professor of Women's Health, Department of Medicine, Monash University Women's Health Program in Australia.
› Verified 4 days ago
| Provider Name | Courtnay Elizabeth Wilson |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1982111241 PECOS PAC ID: 7911268693 Enrollment ID: I20180220001536 |
News Archive
If developing nations shift to using ecological agriculture methods, which rely more on organic and sustainable practices rather than the use of pesticides and chemical fertilizers, they "can double food production within a decade," according to a study by Olivier De Schutter, the U.N. special rapporteur on the right to food, released on Tuesday, Reuters reports.
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
Evidence reported in the October issue of Cell Metabolism, a Cell Press publication, offers a completely new explanation for why people with diabetes account for more than half of all patients requiring dialysis or kidney transplantation. It appears that insulin has a significant influence on the structure and proper function of a particular group of very specialized cells, known as podocytes, that are integral to the kidney's ability to do its job filtering blood.
Children in a malaria-endemic community in Ghana who received a micronutrient powder with iron did not have an increased incidence of malaria, according to a study in the September 4 issue of JAMA. Previous research has suggested that iron supplementation for children with iron deficiency in malaria-endemic areas may increase the risk of malaria.
BioSante Pharmaceuticals, Inc. today announced the initiation of a LibiGel (testosterone gel) clinical trial to evaluate its effect on cognitive function in menopausal women. The trial is a randomized, 6-month comparison of the effect of LibiGel compared to placebo treatment on a variety of learning and memory tasks. The study is being conducted by Dr. Susan Davis, Professor of Women's Health, Department of Medicine, Monash University Women's Health Program in Australia.
› Verified 4 days ago
News Archive
If developing nations shift to using ecological agriculture methods, which rely more on organic and sustainable practices rather than the use of pesticides and chemical fertilizers, they "can double food production within a decade," according to a study by Olivier De Schutter, the U.N. special rapporteur on the right to food, released on Tuesday, Reuters reports.
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
Evidence reported in the October issue of Cell Metabolism, a Cell Press publication, offers a completely new explanation for why people with diabetes account for more than half of all patients requiring dialysis or kidney transplantation. It appears that insulin has a significant influence on the structure and proper function of a particular group of very specialized cells, known as podocytes, that are integral to the kidney's ability to do its job filtering blood.
Children in a malaria-endemic community in Ghana who received a micronutrient powder with iron did not have an increased incidence of malaria, according to a study in the September 4 issue of JAMA. Previous research has suggested that iron supplementation for children with iron deficiency in malaria-endemic areas may increase the risk of malaria.
BioSante Pharmaceuticals, Inc. today announced the initiation of a LibiGel (testosterone gel) clinical trial to evaluate its effect on cognitive function in menopausal women. The trial is a randomized, 6-month comparison of the effect of LibiGel compared to placebo treatment on a variety of learning and memory tasks. The study is being conducted by Dr. Susan Davis, Professor of Women's Health, Department of Medicine, Monash University Women's Health Program in Australia.
› Verified 4 days ago
United Counseling Service Of Bennington County, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 314 Dewey St, Bennington, VT 05201 Phone: 802-442-5491 | |
Mary Jean Sadlak Phd Pc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 160 Benmont Ave, Suite 20, Bennington, VT 05201 Phone: 802-442-3520 Fax: 802-447-3392 | |
Amy Breese, Licsw, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 937 Gage St, Bennington, VT 05201 Phone: 518-469-8704 | |
Roberta K Bennett Md Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 160 Benmont Ave Ste 20, Bennington, VT 05201 Phone: 802-442-3570 Fax: 802-447-3392 | |
Sunrise Family Resource Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 244 Union Street, Bennington, VT 05201 Phone: 802-442-6934 Fax: 802-442-1663 | |
Bennington College Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1 College Dr, Bennington, VT 05201 Phone: 802-440-4426 | |
Hope For Healing Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 160 Benmont Ave Ste C3-80f, Bennington, VT 05201 Phone: 802-494-4040 |